Login to Your Account


Johnson & Johnson showcases its taste for early stage innovation ahead of BIO

By Michael Fitzhugh
Staff Writer

Friday, June 20, 2014
Johnson & Johnson Thursday unveiled a string of new equity investments and research collaborations formed by its network of new innovation centers to advance early stage therapeutic, medical device, diagnostic and consumer health programs. The line-up showcases the work of Johnson & Johnson Innovation LLC just as the industry's next crop of small innovators prepares to meet up with potential partners at the BIO International Convention in San Diego next week.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription